This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Pediatrics  • Pediatrics, Other  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Atik and colleagues¹ studied the prevalence of active trachoma and ocular Chlamydia trachomatis infection in 3 Vietnamese communes. Two communes (Surgery for trachomatous trichiasis; Antibiotics for Chlamydia trachomatis infection; [SA], and Surgery for trachomatous trichiasis; Antibiotics for Chlamydia trachomatis infection; Facial cleanliness; Environmental improvement [SAFE])were selected to receive azithromycin using a targeted approach in which schoolchildren aged 5 to 15 years with signs of active trachoma and their household contacts were treated. A third commune that did not receive oral antibiotics served as a control. Because no association was found between clinical signs and the presence of ocular C trachomatis infection, only a small proportion of infected individuals was treated with azithromycin: 4% and 11% of the 2 SA and SAFE communes, respectively, at baseline; and 0% and 10% at 1 year.

The prevalence of active trachoma declined in all 3 communes from greater than 5% . . . [Full Text of this Article]

David Mabey, MD
David.mabey@lshtm.ac.uk

Robin Bailey, MD, PhD; Anthony Solomon, MB, BS, PhD
Clinical Research Unit

Matthew Burton, MD, PhD; Clare Gilbert, MD; Allen Foster, MD
International Centre for Eye Health
London School of Hygiene & Tropical Medicine
London, England

Thomas Lietman, MD, PhD
Francis I. Proctor Foundation
University of California, San Francisco

Sheila West, PhD
Wilmer Eye Institute
Johns Hopkins Medical Institutions
Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Targeted Treatment of Active Trachoma
Chandler R. Dawson and Julius Schachter
JAMA. 2007;297(6):588-589.
EXTRACT | FULL TEXT  

Targeted Treatment of Active Trachoma—Reply
Deborah Dean, Berna Atik, Ton Thi Kim Thanh, Vu Quoc Luong, and Stephan Lagree
JAMA. 2007;297(6):589-590.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Caution: chlamydia surveillance data ahead
Low
Sex. Transm. Infect. 2008;84:80-81.
FULL TEXT